<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7067438/results/search/disease/results.xml">
  <result pre=": Research Article : Medicine and Health Sciences : Pulmonology:" exact="Respiratory" post="Infections : Biology and Life Sciences : Organisms :"/>
  <result pre="Research Article : Medicine and Health Sciences : Pulmonology: Respiratory" exact="Infections" post=": Biology and Life Sciences : Organisms : Eukaryota"/>
  <result pre=": Biology and Life Sciences : Microbiology : Virology :" exact="Viral" post="Transmission and Infection: Viral Release : Medicine and Health"/>
  <result pre="Sciences : Microbiology : Virology : Viral Transmission and Infection:" exact="Viral" post="Release : Medicine and Health Sciences : Pharmaceutics: Drug"/>
  <result pre="Animal Studies : Animal Models of Disease: Animal Models of" exact="Infection" post=": Biology and Life Sciences : Microbiology: Animal Models"/>
  <result pre=": Biology and Life Sciences : Microbiology: Animal Models of" exact="Infection" post=": Biology and Life Sciences : Microbiology : Virology:"/>
  <result pre="Infection : Biology and Life Sciences : Microbiology : Virology:" exact="Viral" post="Replication : Biology and Life Sciences : Physiology :"/>
  <result pre="antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of" exact="respiratory" post="syncytial virus infection RCT of an antiviral and ibuprofen"/>
  <result pre="nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial" exact="virus infection" post="RCT of an antiviral and ibuprofen in bovine respiratory"/>
  <result pre="anti-inflammatory treatment in a bovine model of respiratory syncytial virus" exact="infection" post="RCT of an antiviral and ibuprofen in bovine respiratory"/>
  <result pre="virus infection RCT of an antiviral and ibuprofen in bovine" exact="respiratory" post="syncytial virus infection http://orcid.org/0000-0003-4059-7115WalshPaulConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationSupervisionValidationVisualizationWriting –"/>
  <result pre="RCT of an antiviral and ibuprofen in bovine respiratory syncytial" exact="virus infection" post="http://orcid.org/0000-0003-4059-7115WalshPaulConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationSupervisionValidationVisualizationWriting – original draftWriting –"/>
  <result pre="of an antiviral and ibuprofen in bovine respiratory syncytial virus" exact="infection" post="http://orcid.org/0000-0003-4059-7115WalshPaulConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationSupervisionValidationVisualizationWriting – original draftWriting –"/>
  <result pre="editing3GershwinLaurel J.ConceptualizationFunding acquisitionInvestigationMethodologyProject administrationResourcesSupervisionWriting – review &amp;amp; editing2*[1], Division of" exact="Pediatric" post="Emergency Medicine, Department of Emergency Medicine, Sutter Medical Center"/>
  <result pre="provided the original author and source are credited.pone.0230245.pdf Abstract Introduction" exact="Bovine" post="respiratory syncytial virus (RSV) is a valid model for"/>
  <result pre="the original author and source are credited.pone.0230245.pdf Abstract Introduction Bovine" exact="respiratory" post="syncytial virus (RSV) is a valid model for human"/>
  <result pre="the two initiated at 3 or 5 days after artificial" exact="infection" post="with bovine RSV in 36 five to six-week-old Holstein"/>
  <result pre="to six-week-old Holstein calves (Bos taurus). We measured clinical scores," exact="respiratory" post="rate, and viral shedding daily for 10 days following"/>
  <result pre="calves (Bos taurus). We measured clinical scores, respiratory rate, and" exact="viral" post="shedding daily for 10 days following inoculation. We estimated"/>
  <result pre="was initiated at 3 days rather than 5 days post" exact="infection" post="with decreased clinical scores and lower respiratory rates at"/>
  <result pre="than 5 days post infection with decreased clinical scores and" exact="lower" post="respiratory rates at both time points. Ibuprofen alone started"/>
  <result pre="5 days post infection with decreased clinical scores and lower" exact="respiratory" post="rates at both time points. Ibuprofen alone started on"/>
  <result pre="increased, and FPI with ibuprofen started on day 3 decreased," exact="viral" post="shedding. Conclusion Dual therapy with Ibuprofen and FPI, on"/>
  <result pre="are within the paper and its Supporting Information files. Introduction" exact="Human respiratory syncytial virus" post="(RSV) causes bronchiolitis in infants and is a common"/>
  <result pre="within the paper and its Supporting Information files. Introduction Human" exact="respiratory" post="syncytial virus (RSV) causes bronchiolitis in infants and is"/>
  <result pre="Supporting Information files. Introduction Human respiratory syncytial virus (RSV) causes" exact="bronchiolitis" post="in infants and is a common cause of morbidity"/>
  <result pre="and is a common cause of morbidity and hospitalization worldwide.[1–3]" exact="Bovine" post="RSV causes an analogous infection in bovine calves and"/>
  <result pre="of morbidity and hospitalization worldwide.[1–3] Bovine RSV causes an analogous" exact="infection" post="in bovine calves and often triggers bovine respiratory disease"/>
  <result pre="an analogous infection in bovine calves and often triggers bovine" exact="respiratory" post="disease complex. Vaccinations are currently not available for children"/>
  <result pre="analogous infection in bovine calves and often triggers bovine respiratory" exact="disease" post="complex. Vaccinations are currently not available for children and"/>
  <result pre="not available for children and bovine vaccines are variably effective." exact="Bovine" post="calves are a good model for human RSV. The"/>
  <result pre="human RSV. The clinical and immunological manifestations are similar, natural" exact="infection" post="fails to induce immunity in both species, and enhanced"/>
  <result pre="fails to induce immunity in both species, and enhanced natural" exact="disease" post="following a specific formalin inactivated vaccine for humans has"/>
  <result pre="increased prostaglandin E among others) is elevated in both human" exact="respiratory" post="epithelium in vitro [9] and in vivo in neonatal"/>
  <result pre="human respiratory epithelium in vitro [9] and in vivo in" exact="neonatal" post="lamb (Ovis aries)[10] and cotton rat (Sigmodon hispidus) models"/>
  <result pre="(Ovis aries)[10] and cotton rat (Sigmodon hispidus) models of RSV" exact="infection" post="[9]. This activity is concentrated in bronchial and bronchiolar"/>
  <result pre="NSAIDs decreases the histopathological changes associated with RSV and other" exact="respiratory" post="viruses.[9] [11, 12] Treatment at 24 hours post inoculation"/>
  <result pre="these studies is that some of the pathology of RSV" exact="infection" post="is self-inflicted by the hosts’ immune system and this"/>
  <result pre="in human infants [13]but is ineffective as antiviral treatment once" exact="infection" post="has occurred.[14] Experiments in a cotton rat model of"/>
  <result pre="has occurred.[14] Experiments in a cotton rat model of RSV" exact="bronchiolitis" post="demonstrated that a combination of anti-RSV antibodies and immunomodulation"/>
  <result pre="immunomodulation with NSAIDs or steroids did improve clinical outcomes following" exact="infection" post="in a way that monotherapy did not. [9, 15]"/>
  <result pre="somewhat better results in animal models. FPI decreased clinical scores," exact="viral" post="shedding, and histology using the same bovine RSV infection"/>
  <result pre="scores, viral shedding, and histology using the same bovine RSV" exact="infection" post="model described here. However, these effects were markedly attenuated"/>
  <result pre="appear reasonably well-tolerated in pre-ruminant calves, although abomasal ulcers and" exact="interstitial nephritis" post="have been reported. [21] We have previously shown improved"/>
  <result pre="reasonably well-tolerated in pre-ruminant calves, although abomasal ulcers and interstitial" exact="nephritis" post="have been reported. [21] We have previously shown improved"/>
  <result pre="We have previously shown improved clinical score but also increased" exact="viral" post="shedding in bovine calves when ibuprofen rather than placebo"/>
  <result pre="the day following inoculation both improved clinical scores and decreased" exact="viral" post="shedding; a smaller benefit was seen when this FPI"/>
  <result pre="earlier work demonstrates the these drugs’ potential but is of" exact="limited" post="practical value because clinical symptoms of RSV typically appear"/>
  <result pre="of RSV typically appear three to five days after inoculation." exact="Failure" post="of these drugs to improve outcomes when started at"/>
  <result pre="this report we answer these questions using clinical parameters and" exact="viral" post="shedding. Materials and methods Study design We conducted a"/>
  <result pre="in 36 bovine calves (Bos taurus) comparing clinical scores and" exact="viral" post="shedding in bovine RSV infected calves treated with ibuprofen,"/>
  <result pre="of these initiated at three or five days after artificial" exact="infection" post="with bovine RSV. The study was approved by the"/>
  <result pre="arm contained a group A and a group B calf." exact="Infection" post="days (study day 0) were one calendar day apart"/>
  <result pre="for each replicate is shown in Table 1. 10.1371/journal.pone.0230245.t001Table 1" exact="Bovine" post="respiratory syncytial virus inoculum titers. Rep. 1A Rep. 1B"/>
  <result pre="each replicate is shown in Table 1. 10.1371/journal.pone.0230245.t001Table 1 Bovine" exact="respiratory" post="syncytial virus inoculum titers. Rep. 1A Rep. 1B Rep."/>
  <result pre="x 10^4 1.2 X10^5 1.29 x 10^5 1.94 x 10^5" exact="Total" post="Dose (5 ml) 6.05 x 10^5 6.8 x 10^5"/>
  <result pre="10^5 6.0 x 10^5 6.45 x 10^5 9.7 x 10^5" exact="Bovine" post="respiratory syncytial virus titers. PFU, plaque forming units. Rep,"/>
  <result pre="6.0 x 10^5 6.45 x 10^5 9.7 x 10^5 Bovine" exact="respiratory" post="syncytial virus titers. PFU, plaque forming units. Rep, replicate."/>
  <result pre="NJ) once daily for three days to prevent stress induced" exact="bacterial" post="pneumonia. Calves were housed in climate controlled barns and"/>
  <result pre="charts as bull charts were not available.[26] Humane endpoints for" exact="infection" post="with bovine RSV were established prior to initiation of"/>
  <result pre="were established prior to initiation of the studies. Since the" exact="disease" post="causes fever, increased respiratory rate, cough, and dyspnea and"/>
  <result pre="initiation of the studies. Since the disease causes fever, increased" exact="respiratory" post="rate, cough, and dyspnea and these clinical signs are"/>
  <result pre="treatment, it was necessary to allow some signs of the" exact="disease" post="to occur. Our criteria for early euthanasia were temperature"/>
  <result pre="singly administered beginning on the day following experimental bovine RSV" exact="infection" post="and beginning on day 3 after infection for FPI,"/>
  <result pre="experimental bovine RSV infection and beginning on day 3 after" exact="infection" post="for FPI, [22, 27] we did not include drug"/>
  <result pre="600mg (regardless of weight) of FPI was given in a" exact="total" post="volume of 30 ml by oral dose syringe once"/>
  <result pre="it assigns a numeric score to constitutional, nasal, ocular, and" exact="respiratory" post="signs based on a structured clinical exam. It is"/>
  <result pre="clinical examinations were also performed in the days prior to" exact="infection" post="with bovine RSV. We also compared the effects of"/>
  <result pre="treatment on clinical score without the temperature component, and on" exact="respiratory" post="rate alone. The exam was recorded in real time"/>
  <result pre="a customized Filemaker-pro 12 database (Filemaker Inc. Santa Clara, CA)." exact="Viral" post="shedding was measured with quantitative RT-PCR on nasopharyngeal swabs"/>
  <result pre="calves’ nostrils. For this purpose, calf nasal swabs collected before" exact="infection" post="and daily after infection were extracted in 400 μl"/>
  <result pre="purpose, calf nasal swabs collected before infection and daily after" exact="infection" post="were extracted in 400 μl of RNALater Stabilization solution"/>
  <result pre="in 350 μl of Buffer RLT—lysis buffer (Qiagen, Hilden, Germany)." exact="Total" post="RNA was extracted from the cell lysate using the"/>
  <result pre="at -80°C until used for further procedures. 10 μl of" exact="viral" post="RNA from each sample was used for reverse transcription."/>
  <result pre="used. RNA from the virus supernatant was extracted using E.Z.N.A." exact="Viral" post="RNA Kit (Omega Bio-tek, Norcross, GA) according to manufacturer’s"/>
  <result pre="performed as described above. Five serial 10x dilutions of standard" exact="viral" post="cDNA was prepared and PCR amplification was performed together"/>
  <result pre="We used the same approach when estimating drug effect on" exact="respiratory" post="rates and viral shedding. The spline (modelling time) and"/>
  <result pre="same approach when estimating drug effect on respiratory rates and" exact="viral" post="shedding. The spline (modelling time) and drug interacted models"/>
  <result pre="into the models but appeared important only when we analyzed" exact="viral" post="shedding and was retained only in these models. Variables"/>
  <result pre="and one in the placebo arm were euthanized for severe" exact="respiratory" post="distress on days 6 and 7 respectively. Both calves"/>
  <result pre="in the first replicate. All calves developed clinical illness and" exact="viral" post="shedding, and all received their assigned treatments. Baseline characteristics"/>
  <result pre="treatment arm analysis showed greater benefit in clinical scores and" exact="respiratory" post="rate when treatment was initiated earlier, and the combination"/>
  <result pre="Score 95% CI Clinical Score excluding temperature 95% CI RR" exact="Viral" post="Load PFU - 95% CI β p lower bound"/>
  <result pre="CI RR Viral Load PFU - 95% CI β p" exact="lower" post="bound upper bound β p lower bound upper bound"/>
  <result pre="Viral Load PFU - 95% CI β p lower bound" exact="upper" post="bound β p lower bound upper bound β p"/>
  <result pre="95% CI β p lower bound upper bound β p" exact="lower" post="bound upper bound β p value upper bound lower"/>
  <result pre="β p lower bound upper bound β p lower bound" exact="upper" post="bound β p value upper bound lower bound β"/>
  <result pre="bound β p lower bound upper bound β p value" exact="upper" post="bound lower bound β p lower bound upper bound"/>
  <result pre="p lower bound upper bound β p value upper bound" exact="lower" post="bound β p lower bound upper bound Ibuprofen Day"/>
  <result pre="bound β p value upper bound lower bound β p" exact="lower" post="bound upper bound Ibuprofen Day 3–10 -31 0.325 -92"/>
  <result pre="p value upper bound lower bound β p lower bound" exact="upper" post="bound Ibuprofen Day 3–10 -31 0.325 -92 31 -33"/>
  <result pre="-3 Placebo arm is referent. FPI; fusion protein inhibitor., RR;" exact="respiratory" post="rate. PFU; plaque forming units. Infecting dose of virus"/>
  <result pre="forming units. Infecting dose of virus p = 0.061 for" exact="viral" post="load analysis. Ibuprofen increased viral shedding while FPI decreased"/>
  <result pre="virus p = 0.061 for viral load analysis. Ibuprofen increased" exact="viral" post="shedding while FPI decreased it. When combined, the effects"/>
  <result pre="the effects of FPI appeared to dominate with respect to" exact="viral" post="load. Analysis by treatment arm showed greater benefit when"/>
  <result pre="data are shown in Fig 4. Fig 4 Mean daily" exact="viral" post="load (copies) for each replicate. Both ibuprofen and FPI"/>
  <result pre="quartile of clinical score using Cox proportional hazard models were" exact="lower" post="in all treatment groups than placebo but the differences"/>
  <result pre="clinical score. Treatment Arm Hazard ratio 95% CI p value" exact="lower" post="bound upper bound Placebo (reference) 1 IbuprofenDay 3–10 0.87"/>
  <result pre="Treatment Arm Hazard ratio 95% CI p value lower bound" exact="upper" post="bound Placebo (reference) 1 IbuprofenDay 3–10 0.87 0.43 1.77"/>
  <result pre="either drug alone. We found ibuprofen increased and FPI decreased" exact="viral" post="shedding but that dual therapy with both drugs led"/>
  <result pre="shedding but that dual therapy with both drugs led to" exact="viral" post="loads comparable to those seen when FPI alone was"/>
  <result pre="that treatment with NSAIDs decreases illness when initiated after RSV" exact="infection" post="has occurred is limited. Richardson et al found some"/>
  <result pre="to simulate an RCT of ibuprofen and acetaminophen in human" exact="bronchiolitis" post="found that both drugs decreased wheezing at 12 months"/>
  <result pre="with time from inoculation initiated treatment on first detection of" exact="viral" post="shedding by PCR again making antivirals of limited practical"/>
  <result pre="detection of viral shedding by PCR again making antivirals of" exact="limited" post="practical clinical use.[17] Jordan et al found decreased clinical"/>
  <result pre="post inoculation in a bovine model as measured by, however" exact="viral" post="shedding was minimally decreased when treatment was started on"/>
  <result pre="widely given in combination with antibiotics to animals with bovine" exact="respiratory" post="disease complex.[31, 32] In this case the primary benefits"/>
  <result pre="given in combination with antibiotics to animals with bovine respiratory" exact="disease" post="complex.[31, 32] In this case the primary benefits being"/>
  <result pre="with bovine respiratory disease complex.[31, 32] In this case the" exact="primary" post="benefits being sought are anti-inflammatory and antipyretic in the"/>
  <result pre="being sought are anti-inflammatory and antipyretic in the context of" exact="bacterial" post="lung infection that frequently complicates bovine RSV.[31] Similarly, the"/>
  <result pre="are anti-inflammatory and antipyretic in the context of bacterial lung" exact="infection" post="that frequently complicates bovine RSV.[31] Similarly, the combination of"/>
  <result pre="the drinking water of piglets decreases the severity of porcine" exact="respiratory" post="disease complex. Bacterial super infection complicates human RSV in"/>
  <result pre="drinking water of piglets decreases the severity of porcine respiratory" exact="disease" post="complex. Bacterial super infection complicates human RSV in at"/>
  <result pre="decreases the severity of porcine respiratory disease complex. Bacterial super" exact="infection" post="complicates human RSV in at least 40% of those"/>
  <result pre="therapy, all being co-administered at the earliest clinical signs of" exact="respiratory" post="infection. Human infant research with FPI for RSV is"/>
  <result pre="respiratory infection. Human infant research with FPI for RSV is" exact="limited" post="because the barriers to research in infants are appropriately"/>
  <result pre="treated at the first appearance of RSV shedding following artificial" exact="infection" post="with human RSV do benefit from FPI.[17] In infants"/>
  <result pre="the first episode of RSV and decreases subsequent physician diagnosed" exact="recurrent" post="wheezing.[35] We speculate that delaying the first episode of"/>
  <result pre="wheezing.[35] We speculate that delaying the first episode of RSV" exact="infection" post="until infants’ Th2 skew has decreased may decrease the"/>
  <result pre="Indeed, Gershwin et al previously showed using this bovine RSV" exact="infection" post="model that infected calves are more predisposed to production"/>
  <result pre="to production of IgE antibodies against aerosolized ovalbumin during active" exact="infection" post="than are uninfected calves [36] and a similar phenomenon"/>
  <result pre="on the third day following inoculation in cotton rats. The" exact="primary" post="limitations to applying this study clinically arise from ongoing"/>
  <result pre="antibodies, but not post-F antibodies are associated with less severe" exact="disease" post="infants)[42] and how to translate the steroid dose used"/>
  <result pre="is so in a later manuscript. Given the potential for" exact="viral" post="resistance to a single FPI, future research may entail"/>
  <result pre="Attempts to correlate the amount of RSV shedding with clinical" exact="disease" post="severity have had mixed results.[43, 44] Prior authors have"/>
  <result pre="have had mixed results.[43, 44] Prior authors have shown that" exact="viral" post="shedding can be effectively eliminated with the early use"/>
  <result pre="ventilation, length of hospital stay, need for supplemental oxygen, or" exact="pulmonary" post="function testing.[45, 46] Steroids and NSAIDs increase viral shedding"/>
  <result pre="oxygen, or pulmonary function testing.[45, 46] Steroids and NSAIDs increase" exact="viral" post="shedding but have either null or beneficial effects on"/>
  <result pre="on various clinical outcomes such as mortality, need for hospitalization," exact="respiratory" post="distress, and subsequent recurrent wheezing.[22, 30, 47–49] We observed"/>
  <result pre="such as mortality, need for hospitalization, respiratory distress, and subsequent" exact="recurrent" post="wheezing.[22, 30, 47–49] We observed that NSAIDs and FPI"/>
  <result pre="5 as monotherapy had almost identical clinical scores despite diverging" exact="viral" post="loads, +174, (95% CI -303, +651) in ibuprofen monotherapy"/>
  <result pre="both drugs was effective at 3 and 5 days after" exact="infection" post="with earlier initiation leading to better outcomes. Supporting information"/>
  <result pre="the generous donation of the FPI and placebo and The" exact="Pediatric" post="Emergency Medicine Research Foundation, Long Beach, CA, for software"/>
  <result pre="entity. References References 1PelletierAJ, MansbachJM, CamargoCAJr. Direct medical costs of" exact="bronchiolitis" post="hospitalizations in the United States. Pediatrics. 2006;118(6):2418–23. Epub 2006/12/05."/>
  <result pre="bronchiolitis, 1993–2004. Ambulatory Pediatrics: the official journal of the Ambulatory" exact="Pediatric" post="Association. 2007;7(4):304–7. 10.1016/j.ambp.2007.03.00617660102 3KubaleJ, KuanG, GreshL, OjedaS, Azziz-BaumgartnerE, SanchezN,"/>
  <result pre="KuanG, GreshL, OjedaS, Azziz-BaumgartnerE, SanchezN, et al.Assessing the incidence of" exact="symptomatic" post="Respiratory Syncytial Virus (RSV) illness within a prospective birth"/>
  <result pre="GreshL, OjedaS, Azziz-BaumgartnerE, SanchezN, et al.Assessing the incidence of symptomatic" exact="Respiratory" post="Syncytial Virus (RSV) illness within a prospective birth cohort"/>
  <result pre="2019/06/29. 10.1093/cid/ciz585 .31257406 4Guerra-MaupomeM, PalmerMV, McGillJL, SaccoRE. Utility of the" exact="neonatal" post="calf model fortesting vaccines and intervention strategies for use"/>
  <result pre="AndersonML, WoolumsAR, LarochelleDR, et al.A bovine model of vaccine enhanced" exact="respiratory" post="syncytial virus pathophysiology. Vaccine. 1998;16(11–12):1225–36. 10.1016/S0264-410X(98)80123-0. 9682383 6KimHW, CancholaJG,"/>
  <result pre="6KimHW, CancholaJG, BrandtCD, PylesG, ChanockRM, JensenK, et al.Respiratory syncytial virus" exact="disease" post="in infants despite prior administration of antigenic inactivated vaccine."/>
  <result pre="ShvedoffRA, StewartCE. An epidemiologic study of altered clinical reactivity to" exact="respiratory" post="syncytial (RS) virus infection in children previously vaccinated with"/>
  <result pre="epidemiologic study of altered clinical reactivity to respiratory syncytial (RS)" exact="virus infection" post="in children previously vaccinated with an inactivated RS virus"/>
  <result pre="study of altered clinical reactivity to respiratory syncytial (RS) virus" exact="infection" post="in children previously vaccinated with an inactivated RS virus"/>
  <result pre="RS virus vaccine. Am J Epidemiol. 1969;89(4):405–21. 10.1093/oxfordjournals.aje.a120954 .4305197 8TaylorG." exact="Bovine" post="model of respiratory syncytial virus infection. Curr Top Microbiol"/>
  <result pre="Am J Epidemiol. 1969;89(4):405–21. 10.1093/oxfordjournals.aje.a120954 .4305197 8TaylorG. Bovine model of" exact="respiratory" post="syncytial virus infection. Curr Top Microbiol Immunol. 2013;372:327–45. 10.1007/978-3-642-38919-1_16"/>
  <result pre="Epidemiol. 1969;89(4):405–21. 10.1093/oxfordjournals.aje.a120954 .4305197 8TaylorG. Bovine model of respiratory syncytial" exact="virus infection." post="Curr Top Microbiol Immunol. 2013;372:327–45. 10.1007/978-3-642-38919-1_16 .24362697 9RichardsonJY, OttoliniMG,"/>
  <result pre="OttoliniMG, PletnevaL, BoukhvalovaM, ZhangS, VogelSN, et al.Respiratory Syncytial Virus (RSV)" exact="infection" post="induces cyclooxygenase 2: A potential target for RSV therapy."/>
  <result pre="therapy. The Journal of Immunology. 2005;174(7):4356–64. 10.4049/jimmunol.174.7.435615778400 10RadiZA, MeyerholzDK, AckermannMR." exact="Pulmonary" post="cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after"/>
  <result pre="Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after" exact="respiratory" post="syncytial virus and parainfluenza virus infection. Viral Immunol. 2010;23(1):43–8."/>
  <result pre="cellular expression and distribution after respiratory syncytial virus and parainfluenza" exact="virus infection." post="Viral Immunol. 2010;23(1):43–8. 10.1089/vim.2009.004220121401 11PrinceGA, PorterDD. Treatment of parainfluenza"/>
  <result pre="and distribution after respiratory syncytial virus and parainfluenza virus infection." exact="Viral" post="Immunol. 2010;23(1):43–8. 10.1089/vim.2009.004220121401 11PrinceGA, PorterDD. Treatment of parainfluenza virus"/>
  <result pre="Viral Immunol. 2010;23(1):43–8. 10.1089/vim.2009.004220121401 11PrinceGA, PorterDD. Treatment of parainfluenza virus" exact="type 3" post="bronchiolitis and pneumonia in a cotton rat model using"/>
  <result pre="2010;23(1):43–8. 10.1089/vim.2009.004220121401 11PrinceGA, PorterDD. Treatment of parainfluenza virus type 3" exact="bronchiolitis" post="and pneumonia in a cotton rat model using topical"/>
  <result pre="11PrinceGA, PorterDD. Treatment of parainfluenza virus type 3 bronchiolitis and" exact="pneumonia" post="in a cotton rat model using topical antibody and"/>
  <result pre="water at a low dose for the treatment of porcine" exact="respiratory" post="disease complex. J Anim Sci. 2013;91(9):4469–75. Epub 2013/07/05. 10.2527/jas.2012-6165"/>
  <result pre="at a low dose for the treatment of porcine respiratory" exact="disease" post="complex. J Anim Sci. 2013;91(9):4469–75. Epub 2013/07/05. 10.2527/jas.2012-6165 .23825328"/>
  <result pre="Anim Sci. 2013;91(9):4469–75. Epub 2013/07/05. 10.2527/jas.2012-6165 .23825328 13Palivizumab, a humanized" exact="respiratory" post="syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial"/>
  <result pre="a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from" exact="respiratory" post="syncytial virus infection in high-risk infants. The IMpact-RSV Study"/>
  <result pre="respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial" exact="virus infection" post="in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998;102(3"/>
  <result pre="syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus" exact="infection" post="in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998;102(3"/>
  <result pre="AlmatarDH, El TatawyLA, DavidsonBL, QusadMIM. Monoclonal antibody treatment of RSV" exact="bronchiolitis" post="in young infants: A Randomized Trial. Pediatrics. 2019;143(3). Epub"/>
  <result pre="HemmingP, OttoliniMG, PrinceGA. Prospects of antiviral and anti-inflammatory therapy for" exact="respiratory" post="syncytial virus infection. Expert review of anti-infective therapy. 2005;3(6):945–55."/>
  <result pre="PrinceGA. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial" exact="virus infection." post="Expert review of anti-infective therapy. 2005;3(6):945–55. 10.1586/14787210.3.6.94516307507 16JordanR, ShaoM,"/>
  <result pre="ShaoM, MackmanRL, PerronM, CihlarT, LewisSA, et al.Antiviral Efficacy of a" exact="Respiratory" post="Syncytial Virus (RSV) Fusion inhibitor in a bovine model"/>
  <result pre="MackmanRL, Scaglioni-WeinlichC, HarrisonL, FarrellE, et al.Oral GS-5806 activity in a" exact="respiratory" post="syncytial virus challenge study. N Engl J Med. 2014;371(8):711–22."/>
  <result pre="Safety Profile: Fifteen years of clinical experience with ibuprofen. The" exact="American" post="Journal of Medicine. 1984;77(1, Part 1):25–34. 10.1016/S0002-9343(84)80015-7. 19WalshP, RothenbergSJ,"/>
  <result pre="NewmanJW, et al.A Randomized placebo controlled trial of ibuprofen for" exact="Respiratory" post="Syncytial Virus infection in a bovine model. PLoS One."/>
  <result pre="Randomized placebo controlled trial of ibuprofen for Respiratory Syncytial Virus" exact="infection" post="in a bovine model. PLoS One. 2016;11(4):e0152913 Epub 2016/04/13."/>
  <result pre="25WoolumsA, AndersonM, GuntherR, SchelegleE, LaRochelleD, SingerR, et al.Evaluation of severe" exact="disease" post="induced by aerosol inoculation of calves with bovine respiratory"/>
  <result pre="severe disease induced by aerosol inoculation of calves with bovine" exact="respiratory" post="syncytial virus. American journal of veterinary research. 1999;60(4):47310211692 26JonesC,"/>
  <result pre="by aerosol inoculation of calves with bovine respiratory syncytial virus." exact="American" post="journal of veterinary research. 1999;60(4):47310211692 26JonesC, HeinrichsJ. Growth charts"/>
  <result pre="inhibitor in a bovine model of RSV infection. 2014. 28CollieD." exact="Pulmonary" post="function changes and clinical findings associated with chronic respiratory"/>
  <result pre="2014. 28CollieD. Pulmonary function changes and clinical findings associated with" exact="chronic" post="respiratory disease in calves. Br Vet J. 1992;148(1):33–40. 10.1016/0007-1935(92)90064-81551012"/>
  <result pre="28CollieD. Pulmonary function changes and clinical findings associated with chronic" exact="respiratory" post="disease in calves. Br Vet J. 1992;148(1):33–40. 10.1016/0007-1935(92)90064-81551012 29KahanBC,"/>
  <result pre="Pulmonary function changes and clinical findings associated with chronic respiratory" exact="disease" post="in calves. Br Vet J. 1992;148(1):33–40. 10.1016/0007-1935(92)90064-81551012 29KahanBC, MorrisTP."/>
  <result pre="use of acetaminophen and or ibuprofen for first episode of" exact="bronchiolitis" post="or respiratory tract infection. PLoS One. 2018;13(9):e0203770 Epub 2018/09/13."/>
  <result pre="acetaminophen and or ibuprofen for first episode of bronchiolitis or" exact="respiratory" post="tract infection. PLoS One. 2018;13(9):e0203770 Epub 2018/09/13. 10.1371/journal.pone.020377030212517 31KahnC,"/>
  <result pre="and ketoprofen as adjuncts to the antibacterial treatment of bovine" exact="respiratory" post="disease. Vet Rec. 2003;152(13):392–4. Epub 2003/04/17. 10.1136/vr.152.13.392 .12696705 33ThorburnK,"/>
  <result pre=".12696705 33ThorburnK, HarigopalS, ReddyV, TaylorN, van SaeneHK. High incidence of" exact="pulmonary" post="bacterial co-infection in children with severe respiratory syncytial virus"/>
  <result pre="33ThorburnK, HarigopalS, ReddyV, TaylorN, van SaeneHK. High incidence of pulmonary" exact="bacterial" post="co-infection in children with severe respiratory syncytial virus (RSV)"/>
  <result pre="High incidence of pulmonary bacterial co-infection in children with severe" exact="respiratory" post="syncytial virus (RSV) bronchiolitis. Thorax. 2006;61(7):611–5. Epub 2006/03/16. 10.1136/thx.2005.048397"/>
  <result pre="van WoenselJBM, BemRA, de JongMD, CalisJCJ. Bacterial co-infection of the" exact="respiratory" post="tract in ventilated children with bronchiolitis; a retrospective cohort"/>
  <result pre="FuruyaH, SimõesEAF, et al.Palivizumab prophylaxis in preterm infants and subsequent" exact="recurrent" post="wheezing. Six-year follow-up study. Am J Respir Crit Care"/>
  <result pre="GuntherRA. Assessment of IgE response and cytokine gene expression in" exact="pulmonary" post="efferent lymph collected after ovalbumin inhalation during experimental infection"/>
  <result pre="in pulmonary efferent lymph collected after ovalbumin inhalation during experimental" exact="infection" post="of calves with bovine respiratory syncytial virus. American Journal"/>
  <result pre="after ovalbumin inhalation during experimental infection of calves with bovine" exact="respiratory" post="syncytial virus. American Journal of Veterinary Research. 2011;72(1):134–45. 10.2460/ajvr.72.1.13421194346"/>
  <result pre="during experimental infection of calves with bovine respiratory syncytial virus." exact="American" post="Journal of Veterinary Research. 2011;72(1):134–45. 10.2460/ajvr.72.1.13421194346 37YouD, BecnelD, WangK,"/>
  <result pre="37YouD, BecnelD, WangK, RippleM, DalyM, CormierSA. Exposure of neonates to" exact="respiratory" post="syncytial virus is critical in determining subsequent airway response"/>
  <result pre="2006;7:107 Epub 2006/08/07. 10.1186/1465-9921-7-10716893457 38PrinceGA, MathewsA, CurtisSJ, PorterDD. Treatment of" exact="respiratory" post="syncytial virus bronchiolitis and pneumonia in a cotton rat"/>
  <result pre="10.1186/1465-9921-7-10716893457 38PrinceGA, MathewsA, CurtisSJ, PorterDD. Treatment of respiratory syncytial virus" exact="bronchiolitis" post="and pneumonia in a cotton rat model with systemically"/>
  <result pre="MathewsA, CurtisSJ, PorterDD. Treatment of respiratory syncytial virus bronchiolitis and" exact="pneumonia" post="in a cotton rat model with systemically administered monoclonal"/>
  <result pre="systemically administered monoclonal antibody (Palivizumab) and glucocorticosteroid. The Journal of" exact="Infectious" post="diseases. 2000;182(5):1326–30. 39RosenbergHF, DomachowskeJB. Inflammatory responses to respiratory syncytial"/>
  <result pre="and glucocorticosteroid. The Journal of Infectious diseases. 2000;182(5):1326–30. 39RosenbergHF, DomachowskeJB." exact="Inflammatory" post="responses to respiratory syncytial virus (RSV) infection and the"/>
  <result pre="Journal of Infectious diseases. 2000;182(5):1326–30. 39RosenbergHF, DomachowskeJB. Inflammatory responses to" exact="respiratory" post="syncytial virus (RSV) infection and the development of immunomodulatory"/>
  <result pre="2000;182(5):1326–30. 39RosenbergHF, DomachowskeJB. Inflammatory responses to respiratory syncytial virus (RSV)" exact="infection" post="and the development of immunomodulatory pharmacotherapeutics. Curr Med Chem."/>
  <result pre="al.Development of motavizumab, an ultra-potent antibody for the prevention of" exact="respiratory" post="syncytial virus infection in the upper and lower respiratory"/>
  <result pre="motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial" exact="virus infection" post="in the upper and lower respiratory tract. J Mol"/>
  <result pre="an ultra-potent antibody for the prevention of respiratory syncytial virus" exact="infection" post="in the upper and lower respiratory tract. J Mol"/>
  <result pre="for the prevention of respiratory syncytial virus infection in the" exact="upper" post="and lower respiratory tract. J Mol Biol. 2007;368(3):652–65. Epub"/>
  <result pre="prevention of respiratory syncytial virus infection in the upper and" exact="lower" post="respiratory tract. J Mol Biol. 2007;368(3):652–65. Epub 2007/02/20. 10.1016/j.jmb.2007.02.024"/>
  <result pre="of respiratory syncytial virus infection in the upper and lower" exact="respiratory" post="tract. J Mol Biol. 2007;368(3):652–65. Epub 2007/02/20. 10.1016/j.jmb.2007.02.024 .17362988"/>
  <result pre="YeF, MertzSE, et al.Prefusion F, postfusion F, G antibodies, and" exact="disease" post="severity in infants and young children with acute respiratory"/>
  <result pre="antibodies, and disease severity in infants and young children with" exact="acute" post="respiratory syncytial virus infection. J Infect Dis. 2017;216(11):1398–406. 10.1093/infdis/jix48929029312"/>
  <result pre="and disease severity in infants and young children with acute" exact="respiratory" post="syncytial virus infection. J Infect Dis. 2017;216(11):1398–406. 10.1093/infdis/jix48929029312 43HasegawaK,"/>
  <result pre="severity in infants and young children with acute respiratory syncytial" exact="virus infection." post="J Infect Dis. 2017;216(11):1398–406. 10.1093/infdis/jix48929029312 43HasegawaK, JarttiT, MansbachJM, LahamFR,"/>
  <result pre="LahamFR, JewellAM, EspinolaJA, et al.Respiratory syncytial virus genomic load and" exact="disease" post="severity among children hospitalized with bronchiolitis: multicenter cohort studies"/>
  <result pre="10.1093/infdis/jiu65825425699 44WrightPF, GruberWC, PetersM, ReedG, ZhuY, RobinsonF, et al.Illness severity," exact="viral" post="shedding, and antibody responses in infants hospitalized with bronchiolitis"/>
  <result pre="severity, viral shedding, and antibody responses in infants hospitalized with" exact="bronchiolitis" post="caused by respiratory syncytial virus. J Infect Dis. 2002;185(8):1011–8."/>
  <result pre="and antibody responses in infants hospitalized with bronchiolitis caused by" exact="respiratory" post="syncytial virus. J Infect Dis. 2002;185(8):1011–8. Epub 2002/04/01. 10.1086/339822"/>
  <result pre=".11930309 45MalleyR, DeVincenzoJ, RamiloO, DennehyPH, MeissnerHC, GruberWC, et al.Reduction of" exact="respiratory" post="syncytial virus (RSV) in tracheal aspirates in intubated infants"/>
  <result pre="MarCB. Immunoglobulin treatment for hospitalised infants and young children with" exact="respiratory" post="syncytial virus infection. Cochrane Database Syst Rev. 2019;8:CD009417 Epub"/>
  <result pre="treatment for hospitalised infants and young children with respiratory syncytial" exact="virus infection." post="Cochrane Database Syst Rev. 2019;8:CD009417 Epub 2019/08/26. 10.1002/14651858.CD009417.pub231446622 47CorneliHM,"/>
  <result pre="et al.A randomized, double-blind, placebo-controlled trial of dexamethasone in severe" exact="respiratory" post="syncytial virus (RSV) infection: effects on RSV quantity and"/>
  <result pre="AhmadN, MejiasA, BuckinghamSC, CarubelliC, KatzK, et al.Effect of dexamethasone on" exact="respiratory" post="syncytial virus-induced lung inflammation in children: results of a"/>
  <result pre="CarubelliC, KatzK, et al.Effect of dexamethasone on respiratory syncytial virus-induced" exact="lung inflammation" post="in children: results of a randomized, placebo controlled clinical"/>
 </snippets>
</snippetsTree>
